Tetraphase Pharmaceuticals, Inc.
TTPH
TTPH was delisted on the 28th of July, 2020.
64 hedge funds and large institutions have $185M invested in Tetraphase Pharmaceuticals, Inc. in 2014 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 29 increasing their positions, 14 reducing their positions, and 15 closing their positions.
107% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 14
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
29% more call options, than puts
Call options by funds: $1.4M | Put options by funds: $1.08M
24% more capital invested
Capital invested by funds: $150M → $185M (+$35.8M)
7% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 15
2% less funds holding
Funds holding: 65 → 64 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
+$3.33M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.12M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.4M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.23M |
| 5 |
BC
Broadfin Capital
New York
|
+$1.15M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.12M |
| 2 |
CPIM
Columbia Partners Investment Management
Alexandria,
Virginia
|
-$2.02M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$1.22M |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.13M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$1.03M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
MCM
76
Manchester Capital Management
Manchester,
Vermont
| – | -$49K | -225 | Closed |
|
|
TRCT
77
Tower Research Capital (TRC)
New York
| – | -$5K | -22 | Closed |
|
78
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$2K | -10 | Closed |
|
79
Ameriprise
Minneapolis,
Minnesota
| – | +$429 | +2 | New |
|
TTPH Hedge Fund Activity: Q2 2014 in Review
64 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in Tetraphase Pharmaceuticals, Inc. (TTPH) for Q2 2014, worth a combined $185M — up 24% from $150M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of TTPH and 14 opened new positions — a net loss of 1 holder — while 14 trimmed existing stakes and 29 added.
The largest buyer was Deerfield Management, opening a new position worth an estimated $3.33M. The largest seller was Millennium Management, cutting an estimated $2.12M.
- 64 institutional investors held Tetraphase Pharmaceuticals, Inc. (TTPH) as of Q2 2014, down from 65 in Q1 2014.
- Funds reported $185M of Tetraphase Pharmaceuticals, Inc. stock for Q2 2014, up 24% quarter-over-quarter.
- 14 funds opened new Tetraphase Pharmaceuticals, Inc. positions in Q2 2014 and 15 closed out, a net change of -1 holder.
- The largest Tetraphase Pharmaceuticals, Inc. buyer in Q2 2014 was Deerfield Management, an estimated $3.33M added.
- The largest Tetraphase Pharmaceuticals, Inc. seller in Q2 2014 was Millennium Management, an estimated $2.12M sold.
Based on aggregated 13F filings for Q2 2014.